Market Cap: $1.08B
IC
IRadimed Corporation
IRMD
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $1.08B
Iradimed's Insider Sale: A Sign of Confidence or Concern? In a recent development within Iradimed Corporation, CEO Roger E. Susi makes headlines following his significant insider sale reported in an S…
Iradimed's Commitment to Innovation in Healthcare Technology Iradimed Corporation, a leader in MRI-compatible intravenous (IV) infusion systems, maintains its focus on advancing patient safety and enh…
Iradimed's Leadership Moves Amidst Innovative Healthcare Developments In a recent filing with the Securities and Exchange Commission (SEC), iRadimed Corporation's CEO, Roger E. Susi, reports an inside…
CEO Insider Sale Sparks Interest in iRadimed's Strategic Direction In a recent filing with the Securities and Exchange Commission (SEC), Roger E. Susi, the CEO of iRadimed Corporation, discloses an in…
Iradimed's Role in Enhanced Patient Safety within MRI Environments Iradimed Corporation, a leader in innovative medical devices, focuses on improving patient safety and care in magnetic resonance imag…
Iradimed's Pioneering Role in MRI-Compatible Infusion Systems Iradimed Corporation continues to revolutionize the medical device landscape with its innovative MRI-compatible infusion systems. The comp…
Iradimed's Technological Advancements in MRI Monitoring Solutions Iradimed Corporation continues to solidify its position within the medical technology sector through its innovative approach to MRI mo…
Iradimed Corporation: Anticipation Builds for Upcoming Earnings Report Iradimed Corporation, a leader in MRI-compatible medical devices, prepares to release its quarterly earnings report on August 1,…
Iradimed Corporation Prepares for Key Earnings Report Amid Competitive Landscape Iradimed Corporation (IRMD), renowned for its cutting-edge MRI-compatible medical devices, gears up to release its late…